What is MOLN stock price today?

Visit our real-time dashboard for the current MOLN stock price and live market data.

Is MOLN stock going up or down today?

MOLN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MOLN stock now?

The decision to buy MOLN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MOLN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MOLN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MOLN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MOLN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MOLN's P/E ratio?

P/E ratio data for MOLN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MOLN's market cap?

MOLN (Molecular Partners AG ADR) has a market capitalization of $0.15 billion, making it a small-cap stock.

What is MOLN's price to book ratio?

Price-to-book ratio for MOLN is available on our dashboard along with other valuation metrics.

Does MOLN pay dividends?

MOLN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MOLN's dividend yield?

MOLN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MOLN stock a good long-term investment?

MOLN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MOLN's revenue growth rate?

Revenue growth data for MOLN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MOLN are available on our dashboard with complete income statement analysis.

What are the risks of investing in MOLN?

Key risks for MOLN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MOLN compare to its competitors?

Compare MOLN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MOLN's performance and positioning.

What is MOLN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for MOLN with bull, base, and bear case scenarios.

What do analysts say about MOLN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MOLN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MOLN's next earnings report?

MOLN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MOLN - Molecular Partners AG ADR

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Molecular Partners AG ADR

Molecular Partners AG ADR (MOLN) common stock

Price Chart

Loading chart...

MOLN Key Statistics

Market Cap

$146.29M

How MOLN Compares to Peers

MOLN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MOLN(This stock)	$146.29M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 8:37 PM EDT

Ready to invest in MOLN?

Commission-free trading available. Affiliate links.

Upcoming Events for MOLN

Dashboard

Enter a ticker to analyze